GALDERMA GROUP AG (1GALD.MI) Stock Price & Overview
BIT:1GALD • CH1335392721
Current stock price
The current stock price of 1GALD.MI is 160 EUR. Today 1GALD.MI is down by -1.23%.
1GALD.MI Key Statistics
- Market Cap
- 38.011B
- P/E
- 71.11
- Fwd P/E
- 40.05
- EPS (TTM)
- 2.25
- Dividend Yield
- 0.23%
1GALD.MI Stock Performance
1GALD.MI Stock Chart
1GALD.MI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to 1GALD.MI.
1GALD.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to 1GALD.MI. 1GALD.MI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
1GALD.MI Earnings
1GALD.MI Forecast & Estimates
20 analysts have analysed 1GALD.MI and the average price target is 198.48 EUR. This implies a price increase of 24.05% is expected in the next year compared to the current price of 160.
For the next year, analysts expect an EPS growth of 46.04% and a revenue growth 18.29% for 1GALD.MI
1GALD.MI Groups
Sector & Classification
1GALD.MI Financial Highlights
Over the last trailing twelve months 1GALD.MI reported a non-GAAP Earnings per Share(EPS) of 2.25. The EPS increased by 166.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.7% | ||
| ROA | 4.58% | ||
| ROE | 7.52% | ||
| Debt/Equity | 0.33 |
1GALD.MI Ownership
1GALD.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1SAN | SANOFI | 9.77 | 100.393B | ||
| SAN | SANOFI | 9.5 | 100.102B | ||
| SNW | SANOFI | 9.73 | 100.041B | ||
| UCB | UCB SA | 25.61 | 51.448B | ||
| UNC | UCB SA | 25.39 | 50.806B | ||
| MRK | MERCK KGAA | 12.98 | 47.739B | ||
| 1MRK | MERCK KGAA | 13.21 | 47.478B | ||
| 1BAYN | BAYER AG-REG | 8.59 | 39.493B | ||
| BAYN | BAYER AG-REG | 8.39 | 38.997B | ||
| IPN | IPSEN | 13.43 | 14.038B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 17.14 | 10.457B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 9.77B | ||
| VIRP | VIRBAC SA | 16.04 | 2.945B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1GALD.MI
Company Profile
Galderma Group AG engages in the provision of science-based premium dermatology solutions. The company is headquartered in Zug, Zug and currently employs 10 full-time employees. The company went IPO on 2024-03-22. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.
Company Info
IPO: 2024-03-22
GALDERMA GROUP AG
Zaehlerweg 10
Zug ZUG CH
Employees: 10
Phone: 41584558592
GALDERMA GROUP AG / 1GALD.MI FAQ
What does GALDERMA GROUP AG do?
Galderma Group AG engages in the provision of science-based premium dermatology solutions. The company is headquartered in Zug, Zug and currently employs 10 full-time employees. The company went IPO on 2024-03-22. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.
Can you provide the latest stock price for GALDERMA GROUP AG?
The current stock price of 1GALD.MI is 160 EUR. The price decreased by -1.23% in the last trading session.
Does 1GALD stock pay dividends?
GALDERMA GROUP AG (1GALD.MI) has a dividend yield of 0.23%. The yearly dividend amount is currently 0.15.
What is the ChartMill technical and fundamental rating of 1GALD stock?
1GALD.MI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the sector and industry classification for GALDERMA GROUP AG?
GALDERMA GROUP AG (1GALD.MI) operates in the Health Care sector and the Pharmaceuticals industry.
How is the valuation of GALDERMA GROUP AG (1GALD.MI) based on its PE ratio?
The PE ratio for GALDERMA GROUP AG (1GALD.MI) is 71.11. This is based on the reported non-GAAP earnings per share of 2.25 and the current share price of 160 EUR.
Should I buy 1GALD stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1GALD.MI.